Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
4 and 8 mg Ondansetron ready for submission in EU (exp. Q4/08) using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
The present technology describes recombinant poxvirus vectors encoding at least three or more costimulatory molecules and TAAs. More
Dynamic treatment simulation software system for Intensity Modulated Radiation Therapy (IMRT) prior to the initiation of actual therapy More
The present technology describes recombinant poxvirus vectors encoding at least three or more costimulatory molecules and tumor associated antigens (TAAs). More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 19 pages - $99
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Nov 2010 - 26 pages - $125
Nov 2009 - $15,200
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Anti-angiogenesis
- Cancer Antibodies
- Chemotherapy
- Radioimmunotherapy
- Radiotherapy
- Vaccines
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us